| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |